✦ LIBER ✦

Antisense therapy for cancer

✍ Scribed by F.E Cotter

Book ID: 118620130
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 167 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)00011-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Gleave, Martin E.; Monia, Brett P. 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 462 KB

Antisense therapy in cancer

✍ W. Pawlak; J. Zolnierek; T. Sarosiek; C. Szczylik 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 233 KB

Antisense oligonucleotides for cancer th

Antisense oligonucleotides for cancer therapy—an overview

✍ Stahel, Rolf A.; Zangemeister-Wittke, Uwe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Development of Antisense Therapeutics: I

Development of Antisense Therapeutics: Implications for Cancer Gene Therapy

✍ JOHN F. MILLIGAN; ROBERT J. JONES; BRIAN C. FROEHLER; MARK D. MATTEUCCI 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 798 KB

Antisense therapy for lymphomas

✍ Finbarr E. Cotter 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

  antisense; BCL-2; apoptosis; lymphoma 'gene silencing', by synthetic oligonucleotides, as a therapeutic tool. In the field of lymphomas obvious targets include follicular lymphoma with the t(14;18) translocation, deregulated expression of the BCL-2 gene, chemoresistance and subsequent prot

Antisense therapy for melanoma

✍ Ernest C. Borden 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 75 KB